CIK: 1494892 - Address: C/o Ariad Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA 02139
20 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11200-12420187
S%wins60604530303944

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/22/16 16:01
3/21/16
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-236.4730-4-2147D-20-26-194411044-5-8101384
3/3/16 19:58
3/3/16
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-656.1120-11-7144D-27-21-33-2153624184444469
2/3/16 16:39
2/1/16
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-784.8123-16-11135D-32-21-38-27-19-14-926-9204093375
9/28/15 17:40
9/28/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-366.4633-6-4122D-6425-20-20-7-15-15-8-7483-1114
7/16/15 17:08
7/16/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-388.5421-4-4118D-605031-6-6-4552-3-14-23-38-18
3/23/15 17:54
3/20/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.dm-608.7133-7-6114D-587513731860-2-282-7-24
2/4/15 16:52
2/2/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-1026.3333-16-13108D-68-6148-11160109314329-19
4/3/14 16:32
4/2/14
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-288.2133-3-3104D-49-52-5718-8761-2-2-7-16-315
3/21/14 17:28
3/21/14
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-197.8933-2-299D-47-60-619513-663-3-3-6-16-2610
12/20/13 16:33
12/19/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS-265.1433-5-591D-51-73-67-7314114244394622315
7/18/13 17:51
7/18/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS-12719.7933-6-784D6112-3718110-80-5-10-82-68-77
4/3/13 16:57
4/2/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-6118.0433-3-474D1339-24-10-17-21-11-5242169-47
3/26/13 16:36
3/25/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-10118.8833-5-769D18720-23-11-8-14-17-101-3-2-911-56
3/22/13 18:29
3/22/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-4719.4633-2-461D20829-16-20-6-11-8-5-7-4-1311-59
5/4/12 16:29
5/2/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-5117.0033-3-650D3041014684107002-312349
4/3/12 17:53
4/3/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-6916.1833-4-850D353108853212741-1-8411474
3/28/12 16:15
3/26/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-4816.0033-3-646D365123603771143-11394414
3/26/12 16:45
3/23/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-10315.4133-7-1346D36412763367744-1-2-774613
3/21/12 18:05
3/20/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-22515.0233-15-2839D3591324633-452-335-3155727
2/23/12 16:32
2/21/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagHaluska FrankMAOSVP,ClinS.d-6514.5133-5-1624D48815177425-3-1-6-1-63102841

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact